Alamar Biosciences, Inc.

🧠 Experience pTau and Beyond at AD/PD 2025! 🧠 📅 Don’t miss our Product Theater featuring data from Nicholas Ashton, PhD (Banner Sun Health / University of Gothenburg) 📍 Thursday, April 3 | 10:40–11:10 AM | Exhibition Hall 🧾 Stop by our 12 posters to see how NULISA is accelerating fluid biomarker discovery in Alzheimer’s and Parkinson’s disease. 👋 Come say hi at Booth #22C — we’d love to show you a demo of the ARGO HT System in action! Let’s connect in Vienna! Learn more: https://ow.ly/UfY350VoYPc #ADPD2025 #Neurodegeneration #Biomarkers #Alzheimers #Parkinsons #Proteomics #NULISA #ARGOHT

🐭 Calling all mouse model researchers! 🐭 Got a project in immunology, oncology, or neurodegeneration? Apply now for Alamar’s Mouse Grant Program — five winners will receive free analysis of 86 samples using our high-sensitivity NULISAseq™ Mouse Panel 120. 🔬 120+ protein targets 🧠 Focus on inflammation, neurodegeneration, and cancer 📉 Detect low-abundance biomarkers with attomolar sensitivity ⏳ Deadline: May 16, 2025 Accelerate your biomarker discovery, therapeutic development, or disease mechanism studies with cutting-edge multiplex technology. 👉 Apply now: https://ow.ly/CYah50VnsSL #MouseModels #Proteomics #PreclinicalResearch #BiomarkerDiscovery #Neuroscience #Oncology #Immunology #NULISAseq

Jumpstart your #ABRF2025 conference day with breakfast, coffee, and a deep dive into our cutting-edge #NULISA technology! ☕🍳🚀 Join our Breakfast Technology Showcase in Skyview 4 (26th floor), at 7:45 am, to explore how high-sensitivity proteomic profiling using #NULISAseq panels for human and mouse are unlocking new insights in Multi-omic studies. 👉 Visit us at Booth 233 after the showcase to speak with our team about your research goals and to demo the fully-automated #ARGO HT System: https://lnkd.in/gXM3JwR5

🐭New product launch! 🐭 Alamar Biosciences is proud to announce the #NULISAseq Mouse Panel 120 — the most comprehensive, high-sensitivity protein biomarker panel for mouse models. 🔬 120 protein targets - the largest panel commercially available 🧠 Focus on neuro, inflammation & immuno-oncology - the only panel to offer comprehensive coverage of neuro targets 📉 Detect low-abundance proteins from just 5 µl of plasma - low volumes required “This state-of-the-art panel provides me with the broadest view of neuro-physiology and has the potential to uncover new insights into the mechanisms of dementia and traumatic brain injury,” said Cheryl Wellington, Ph.D., Professor, Department of Pathology and Laboratory Medicine at The University of British Columbia. ➡️ Learn more: https://ow.ly/AO6I50VnlzC #Proteomics #PreclinicalResearch #Neuroscience #Biomarkers #DrugDiscovery

🌍 Expanding Global Access to Precision Proteomics! Alamar Biosciences is partnering with five leading distributors to bring our high-sensitivity proteomics solutions to more researchers worldwide! 🎉 🔹 GeneWorks – Australia & New Zealand 🔹 Genomax – Singapore 🔹 PhileKorea – South Korea 🔹 Scrum Inc. – Japan 🔹 Spinco – India “These partners will help accelerate access to our next-gen proteomics tools for biomarker discovery, drug development, and disease research,” said Yuling Luo, Ph.D., CEO of Alamar Biosciences. 📢 Learn more: https://ow.ly/ATOO50VkGlX #Proteomics #LifeSciences #Biomarkers #DrugDiscovery #ScientificInnovation

We're thrilled to be attending the 13th Annual Parkinson’s & Drug Development Summit in Boston today! Join our partnership presentation this morning to hear from Dr. Christopher Bunker, VP of Biopharma Business Development at Alamar, on how #NULISA, the only high-plex, high-sensitivity platform, is transforming biomarker research for neurodegenerative diseases and treatment response. We look forward to connecting with experts driving innovation in Parkinson’s research and neurodegenerative disease drug development 👉 https://ow.ly/iXTv50VktPF #ParkinsonsDisease #Neurodegeneration #Biomarkers #DrugDevelopment

Don’t Miss Our Technology Showcase at #ABRF2025! Join us on Monday, March 24 at 7:45 am in Skyyview 4 to hear Dr. Robert Chen from Weill Cornell Medicine, highlight how our #NULISAseq Panels for human and mouse are advancing #proteomics research with high sensitivity, unlocking new insights in multi-omic studies. Be sure to stop by booth 233 to connect with our team and discover how our cutting-edge #NULISA technology can elevate your research 👉 https://ow.ly/zjMg50VkcXo

🚨 We're heading to Las Vegas for #ABRF2025! 🚨 As a returning sponsor, we are excited to connect with the core facility and research community at this premier event. Stop by booth 233 to learn how our cutting-edge #NULISA technology supports breakthroughs in #immunology, #neurodegeneration, and cancer research—empowering biomolecular resource facilities with advanced solutions for multi-omics and precision medicine. Meet our team and discover how we can support your research goals! Learn more about our ABRF activities here 👉 https://ow.ly/Q5RT50Vhyi3 #CoreFacilities #PrecisionMedicine #CancerResearch

🧠 Thank you for joining us at Translation 2025! 🧠 As the event comes to a close, we’re grateful for the insightful discussions and collaborations driving progress in dementia research. At Alamar Biosciences, we are dedicated to advancing research for early disease detection for neurologic disorders like #dementia and Alzheimer's disease with our groundbreaking #NULISA protein #biomarker detection technology. Learn more about NULISA and its impact on neurodegenerative disease research 👉 https://ow.ly/3lNU50VioUK #Translation2025 #DementiaResearch #DPUK #DementiasPlatformUK

🚨 We're heading to Las Vegas for #ABRF2025! 🚨 As a returning sponsor, we are excited to connect with the core facility and research community at this premier event. Stop by booth 233 to learn how our cutting-edge #NULISA technology supports breakthroughs in #immunology, #neurodegeneration, and cancer research—empowering biomolecular resource facilities with advanced solutions for multi-omics and precision medicine. Meet our team and discover how we can support your research goals! Learn more about our ABRF activities here 👉 https://ow.ly/Q5RT50Vhyi3 #CoreFacilities #PrecisionMedicine #CancerResearch